Asset Details
Do you wish to reserve the book?
Clinical application of human umbilical cord-derived mesenchymal stem cells for small articular cartilage defects of the knee in military training-related injuries
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Clinical application of human umbilical cord-derived mesenchymal stem cells for small articular cartilage defects of the knee in military training-related injuries
Do you wish to request the book?
Clinical application of human umbilical cord-derived mesenchymal stem cells for small articular cartilage defects of the knee in military training-related injuries
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Clinical application of human umbilical cord-derived mesenchymal stem cells for small articular cartilage defects of the knee in military training-related injuries
2025
Overview
To explore the short-term efficacy and safety of umbilical cord-derived mesenchymal stem cells(UC-MSCs) in patients with small articular cartilage defects of the knee.
This was a retrospective study from August 2020 to December 2020, thirty two patients with knee cartilage injuries caused by military training were admitted to the Department of Orthopedics in The General Hospital of North Theater Command Training Base included in the study. Group-A (n=11) underwent microfracture surgery, Group-B(n=10) underwent arthroscopic exploration and injected umbilical cord mesenchymal stem cells (UC MSCs) into the knee joint cavity, and Group-C (n=11) underwent microfracture surgery and injected UC MSCs into the knee joint cavity. Clinical data were collected from three groups of patients.
The Lysholm scores of the three groups gradually increased, from 51.00 ± 1.6, 51.50 ± 2.2, and 50.91 ± 2.4 points before treatment to 74.64 ± 2.4, 79.40 ± 4.3, and 78.73 ± 4.2 points at the last follow-up (P<0.05), respectively. The AKSS scores also showed similar therapeutic effects. During the follow-up of six, nine, and 12 months after treatment, the scores of Group-B and C were higher than Group-A (P<0.05), while Groups-B and C had similar efficacy(P>0.05).
The application of microfracture combined with UC MSCs injection or UC MSCs injection alone for small cartilage defects in the knee joint can achieve certain therapeutic effects in the short term, but as a new technology, stem cells need further observation for long-term efficacy.
